A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

NCT00393484 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Lamivudine Placebo
DRUG: Lamivudine
DRUG: Entecavir Placebo

Sponsor

Bristol-Myers Squibb